drugset / Trial / NCT01670019
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 6-week comparison of asenapine versus placebo as an add-on to ongoing antidepressant treatment in patients with major depression who have not had a complete therapeutic response to treatment with the antidepressant alone. The investigators hypothesize that added asenapine will produce greater reductions in depression than will added placebo.
Timeline
- Start
- 2012-10
- Primary completion
- 2014-05
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asenapine | Other / unclassified | 5 mg | — |
| Subject | Asenapine | Other / unclassified | 10 mg | — |
| Subject | Asenapine | Other / unclassified | 15 mg | — |
| Subject | Asenapine | Other / unclassified | 20 mg | — |